It does look like this cluster of researchers is making progress.
Treatment of aged mice with the nucleoside reverse transcriptase inhibitor lamivudine downregulated IFN-I activation and age-associated inflammation (inflammaging) in several tissues.
Lamivudine is also called 3TC, and it’s already approved for use against HIV. A clinical trial on its efficacy against Alzheimer’s is underway and scheduled to be complete in June 2022.
It does look like this cluster of researchers is making progress.
Lamivudine is also called 3TC, and it’s already approved for use against HIV. A clinical trial on its efficacy against Alzheimer’s is underway and scheduled to be complete in June 2022.